JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A3007 ABT-263 (Navitoclax)
58 Citation

Target: Bcl-2|Bcl-w

Summary: Bcl-2 family inhibitor

≥48.73 mg/mL
A3008 Y-27632 dihydrochloride
75 Citation

Target: ROCK

Summary: ROCK inhibitor

≥111.2 mg/mL
A3012 Ruxolitinib (INCB018424)
12 Citation

Target: JAK

Summary: JAK1 and JAK2 inhibitor

insoluble in H2O; ≥15.32 mg/mL
A3023 P005091
1 Citation

Target: Ubiquitin-specific proteases

Summary: Ubiquitin-specific protease 7 (USP7) inhibitor

insoluble in H2O; insoluble in EtOH; ≥17.4 mg/mL
A2575 Bestatin

Target: Aminopeptidases

Summary: Aminopeptidase inhibitor

insoluble in H2O; insoluble in EtOH; ≥12.34 mg/mL
A4015 Disulfiram
2 Citation

Target: Aldehyde Dehydrogenases

Summary: Dopamine β-hydroxylase inhibitor

insoluble in H2O; ≥12 mg/mL
A4079 Fosinopril sodium

Summary: ACE inhibitor
A4080 Moxonidine

Summary: I1R/α2AR agonist

insoluble in H2O; ≥11.3 mg/mL
A4187 FG-4592 (ASP1517)
5 Citation

Summary: HIF prolyl-hydroxylase inhibitor

insoluble in H2O; ≥17.62 mg/mL
A4190 GSK J4 HCl
1 Citation

Summary: Inhibitor of H3K27 demethylase JMJD3,potent and cell-permeable

insoluble in H2O; insoluble in EtOH; ≥13.9 mg/mL